Risk Analysis of Measles Bulk Production Facility at PT VXN

Infrastructure development in Indonesia is supported by APBN which has consistently increased since 2015. A management system is certainly required in developing the public infrastructure, as well as the support facilities on production process in life science industry. Vaccine produces an active im...

Full description

Saved in:
Bibliographic Details
Main Author: Viodita Maharani / 29116045, Shinta
Format: Theses
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/30935
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:30935
spelling id-itb.:309352018-08-10T09:29:01ZRisk Analysis of Measles Bulk Production Facility at PT VXN Viodita Maharani / 29116045, Shinta Indonesia Theses INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/30935 Infrastructure development in Indonesia is supported by APBN which has consistently increased since 2015. A management system is certainly required in developing the public infrastructure, as well as the support facilities on production process in life science industry. Vaccine produces an active immunity to a disease which its manufacturing process takes a very long time and complicated. As an authorized company, PT VXN is always innovate the vaccine production to updates every product which began to fall in demand. National and International vaccine demand data states that the demand for Measles vaccine is projected to continue to increase, even now, it is exceed the capacity of available products. Efforts to increase the production capacity are very important through the development in production facilities. <br /> <br /> <br /> Company analysis by internal and external environment need to be done to understand the business situation. The author uses PESTE and Porter's Five Forces analysis for external analysis. Resource analysis for internal analysis. Discovered the opportunities and threats in external and internal analysis related to revenue growth through the product diversification. In this study also found the strengths and weaknesses owned by PT VXN in running this industry. <br /> <br /> <br /> First of all, the author have to analyze the SWOT, other similar research, and FGD with PT VXN management team to identify risks. There are five categories of risk includes business/market, finance, operational/quality, strategic, and OHS. The probability weight of risk in this research obtained from interviews, while the impact weight used sensitivity and uncertainty analysis through Expert Judgment. There are ten risks that prioritize to be mitigated since the possibility and impact are resulted. text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
description Infrastructure development in Indonesia is supported by APBN which has consistently increased since 2015. A management system is certainly required in developing the public infrastructure, as well as the support facilities on production process in life science industry. Vaccine produces an active immunity to a disease which its manufacturing process takes a very long time and complicated. As an authorized company, PT VXN is always innovate the vaccine production to updates every product which began to fall in demand. National and International vaccine demand data states that the demand for Measles vaccine is projected to continue to increase, even now, it is exceed the capacity of available products. Efforts to increase the production capacity are very important through the development in production facilities. <br /> <br /> <br /> Company analysis by internal and external environment need to be done to understand the business situation. The author uses PESTE and Porter's Five Forces analysis for external analysis. Resource analysis for internal analysis. Discovered the opportunities and threats in external and internal analysis related to revenue growth through the product diversification. In this study also found the strengths and weaknesses owned by PT VXN in running this industry. <br /> <br /> <br /> First of all, the author have to analyze the SWOT, other similar research, and FGD with PT VXN management team to identify risks. There are five categories of risk includes business/market, finance, operational/quality, strategic, and OHS. The probability weight of risk in this research obtained from interviews, while the impact weight used sensitivity and uncertainty analysis through Expert Judgment. There are ten risks that prioritize to be mitigated since the possibility and impact are resulted.
format Theses
author Viodita Maharani / 29116045, Shinta
spellingShingle Viodita Maharani / 29116045, Shinta
Risk Analysis of Measles Bulk Production Facility at PT VXN
author_facet Viodita Maharani / 29116045, Shinta
author_sort Viodita Maharani / 29116045, Shinta
title Risk Analysis of Measles Bulk Production Facility at PT VXN
title_short Risk Analysis of Measles Bulk Production Facility at PT VXN
title_full Risk Analysis of Measles Bulk Production Facility at PT VXN
title_fullStr Risk Analysis of Measles Bulk Production Facility at PT VXN
title_full_unstemmed Risk Analysis of Measles Bulk Production Facility at PT VXN
title_sort risk analysis of measles bulk production facility at pt vxn
url https://digilib.itb.ac.id/gdl/view/30935
_version_ 1822267611668283392